Multiple Myeloma Symposium: Emerging Treatment Options | Dana-Farber Cancer Institute

Kenneth C. Anderson, MD, director of the Jerome Lipper Multiple Myeloma Cancer and LeBow Institute for Myeloma Therapeutics at Dana-Farber Cancer Institute, explores the emerging treatment options for patients with multiple myeloma. This presentation was originally given at the Multiple Myeloma Patient Education Symposium on Dec. 13, 2014 in Boston, MA. Learn more about Dana-Farber's research and treatment for multiple myeloma at http://www.dana-farber.org/Adult-Care/Treatment-and-Support/Treatment-Centers-and-Clinical-Services/Hematologic-Oncology-Treatment-Center/Multiple-Myeloma-Program.aspx.